跳到正文
原文
Medical Xpress·· 21 天前精选AI 评分63

南非随机试验:孕期两次筛查并治疗三种性传播感染与早产风险降低相关

STI screening linked to fewer preterm births

AI 导读

一项在南非四家政府诊所开展的随机试验显示,孕期两次筛查并治疗衣原体、淋病和滴虫病者早产率为14.5%,标准照护组为18.8%。单次筛查组早产率为18.9%,与标准照护组接近;两次筛查未显著降低早产或低出生体重的复合主要终点。研究纳入2247名孕妇,约27%入组时至少感染一种目标病原体,其中约80%无症状,作者表示早产相关结果仍需进一步研究。

推荐理由

随机试验给出孕期两次筛查与早产率差异的具体数据,但主要复合终点未达显著,作者提示仍需进一步研究。

正文
STI screening linked to fewer preterm births
Graphical Abstract. Credit: Clinical Infectious Diseases (2026). DOI: 10.1093/cid/ciag577

Screening and treating pregnant patients for three common sexually transmitted infections (STIs) twice during pregnancy was associated with a 23% lower risk of preterm birth compared with standard care, according to a randomized clinical trial published in Clinical Infectious Diseases from researchers at the University of Pennsylvania and University of Southern California.

In practical terms, 14.5% of participants who received screening and treatment twice during pregnancy had a preterm birth, compared with 18.8% of those receiving standard care. Screening only once was not associated with a reduction in preterm birth.

"Complications from preterm birth are among the leading causes of death among children under 5 years of age globally. This study suggests that testing for STIs during pregnancy could help us find and treat infections that might otherwise go unnoticed, and that screening more than once may be important for reducing the risk of preterm birth," said co-lead author Andrew Medina-Marino, Ph.D., adjunct associate professor of psychiatry at the University of Pennsylvania Perelman School of Medicine.

"Because most of the infections we found caused no symptoms, waiting for symptoms alone means we may miss an opportunity to intervene."

Most infections caused no symptoms

The trial focused on three common, treatable STIs: chlamydia, gonorrhea and trichomoniasis. These infections have been linked to preterm birth and low birth weight. However, whether routine screening and treatment during pregnancy can improve birth outcomes has remained uncertain.

Researchers enrolled 2,247 pregnant participants at four government health clinics in South Africa and randomly assigned them to one of three groups: screening and treatment at their first prenatal visit with a test-of-cure three weeks later for women treated for a detected STI; screening and treatment at their first visit and again between 30 and 34 weeks of pregnancy; or standard care, in which treatment was based on symptoms.

At the start of the study, about 27% of participants tested positive for at least one of the three STIs, and approximately 80% of those infections caused no symptoms.

Among participants who were screened again in their third trimester, 9.2% tested positive at that visit. Some infections persisted or returned, while others were newly detected in participants who had tested negative earlier in pregnancy.

Results point to potential value of screening

Researchers found preterm birth among 14.5% of participants screened twice, compared with 18.8% receiving standard care. The one-time screening group had a nearly identical preterm birth rate to the standard-care group, at 18.9%.

The twice-during-pregnancy approach did not, however, significantly reduce the study's primary combined outcome of preterm birth or low birth weight. It also did not reduce low birth weight when researchers considered that outcome separately. The authors therefore caution that the finding on preterm birth needs further study.

"The results give us an important signal, but they don't settle the question of how often pregnant patients should be screened," Medina-Marino said. "The next step is understanding when screening can have the greatest impact and which patients are most likely to benefit."

Building evidence for prenatal screening

The optimal timing of STI screening during pregnancy remains unclear. In this trial, participants entered the study at a median of 13 weeks of pregnancy. Researchers said testing later in pregnancy may have provided another opportunity to identify persistent or newly acquired infections, although additional studies are needed to confirm that explanation.

The authors noted several limitations. The trial was conducted in a single South African setting where STI prevalence was high, which could limit how broadly the findings apply elsewhere. The study also was not designed to determine definitively whether screening benefited particular subgroups of patients.

Still, the researchers said the findings add to growing evidence about whether, when and for whom STI screening during pregnancy could improve birth outcomes, including in higher-income countries such as the United States.

Publication details

Andrew Medina-Marino et al., Antenatal Screening for Sexually Transmitted Infections to Reduce Preterm Birth or Low Birthweight (Philani Ndiphile Study): A Randomized 3-Group Trial, Clinical Infectious Diseases (2026). DOI: 10.1093/cid/ciag577

Journal information: Clinical Infectious Diseases

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: STI screening linked to fewer preterm births (2026, October 29) retrieved 29 October 2026 from https://medicalxpress.com/news/2026-10-sti-screening-linked-preterm-births.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com